AI
| Followers | 843 |
| Posts | 122881 |
| Boards Moderated | 9 |
| Alias Born | 09/05/2002 |
Saturday, August 25, 2007 3:56:50 PM
Re: LA Times profile of Dr. Lynch
>With a Nobel behind it and a very important role in vascular tension, i would think nitric oxide is the kind of disappointment that most research labs could live with!<
To be fair, they also have to live with the debacle called Nitromed
Seriously, though, there were several errors in the LA Times series on Dr, Lynch. Perhaps the most significant one for investors is the manner in which the article overstated COR’s results in ADHD. It was nonetheless a good read, IMO.
>With a Nobel behind it and a very important role in vascular tension, i would think nitric oxide is the kind of disappointment that most research labs could live with!<
To be fair, they also have to live with the debacle called Nitromed
Seriously, though, there were several errors in the LA Times series on Dr, Lynch. Perhaps the most significant one for investors is the manner in which the article overstated COR’s results in ADHD. It was nonetheless a good read, IMO.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
